Publications by the researcher in collaboration with David Díaz Valle (20)

2024

  1. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

    Ophthalmology and Therapy, Vol. 13, Núm. 6, pp. 1669-1682

2023

  1. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  2. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

  3. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2022

  1. Clinical Features and Outcomes of Tubulointerstitial Nephritis and Uveitis Syndrome in Spain and Portugal: The IBERTINU Project

    Ocular Immunology and Inflammation, Vol. 31, Núm. 2, pp. 286-291

  2. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

  3. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2021

  1. Multicentre study: Reliability and repeatability of Scheimpflug system measurement in keratoconus

    British Journal of Ophthalmology, Vol. 105, Núm. 1, pp. 22-26

2020

  1. Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

    Frontiers in Immunology, Vol. 11

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  2. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study

    BMC Ophthalmology

  2. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative

    Ophthalmology, Vol. 125, Núm. 5, pp. 757-773

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

2016

  1. Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain

    Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152

2015

  1. Study of association of CTLA4 gene variants to non-anterior uveitis

    Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376

2013

  1. Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition

    BMC Medical Genetics, Vol. 14, Núm. 1

  2. No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis

    PLoS ONE, Vol. 8, Núm. 11

  3. Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Comparative study of limbal stem cell deficiency diagnosis methods: Detection of MUC5AC mRNA and goblet cells in corneal epithelium

    Ophthalmology, Vol. 119, Núm. 5, pp. 923-929